Table of Contents
Description
Priority Announcements on CIHR Operating Grant competitions offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas or mandates. Applications are submitted through the "201009MOP" competition of the Operating Grant: 2010-2011 funding opportunity.
Funds Available
CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations. Should CIHR funding levels be decreased by Parliament, CIHR reserves the right to defer or suspend payments to grants received as a result of this funding opportunity.
Funds Available for Research in All Areas
Funds are available for applications in all areas of research that address any important health problem or issue through the "201009MOP" competition of the Operating Grant: 2010-2011 funding opportunity.
Funds Available for Research in Specific Areas
In this competition, funds are available to encourage and support applications in specific areas that are aligned with CIHR's research priority areas and mandates. Information on the research areas to be funded as well as the maximum amounts per grant that can be requested is found in the "Objectives" section.
- Blood Supply Risk
- Blood Utilization and Conservation
- Breast Cancer (Updated: 2010-07-15)
- Ethics
- Gender, Sex and Health Research
- Genetics (Ethics, Law and Society)
- Health Services and Policy Research
- HIV/AIDS
- INMD Start Up Funds (Bridge Funding)
- Knowledge Translation
- Obesity – Prevention and Treatment
- Ovarian Cancer (Bridge Funding) (Updated: 2010-07-15)
- Prevention and Treatment of Illicit Drug Use
- Psychosocial Issues Related to Assisted Human Reproduction
- Regional Partnerships Program
- Reproductive and Child Heath (Start-up Grants)
- Sodium and Health
- Transfusion Related Acute Lung Injury (TRALI)
B. Research Related to CIHR Institute Mandates:
- Cancer Research (Bridge Funding)
- Circulatory and Respiratory Health (Bridge Funding)
- Genetics (Bridge Funding)
- Genetics: Maud Menten New Principal Investigator Prizes
- Institute of Infection and Immunity (Bridge Fund.)
- INMHA (Bridge Funding)
- Musculoskel. Health, Arthritis, Skin and Oral Health
- Nutrition, Metabolism and Diabetes (Bridge Funding)
- Spinal Cord Research (Prize)
Top
Objectives
The specific objective of the Operating Grant Priority Announcement (Specific Research Areas) is to offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas and mandates.
A. CIHR Research Priority Areas:
1. Blood Supply Risk (BSR)
Summary:
- The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH), in partnership with Canadian Blood Services (CBS), will fund applications that are determined to be relevant to the research priority areas described below:
- Blood supply risk.
- Examples of relevant questions include research on:
- Blood donor deferral strategies and the risk of transmission of blood borne diseases
- Policy development and social aspects of blood system safety and risk tolerance
- Emerging pathogens in specific populations including sexually active gay men
- More information on the research priorities of CIHR-ICRH and CBS can be found on their websites.
Funds Available:
- The term of the grant is up to three years.
- The total number and amount of grants to be funded will be determined by CBS following peer review evaluation.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
- The grant must be held in Canada.
- Funding will be provided directly by the Canadian Blood Services.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
2. Blood Utilization and Conservation (BUC)
Summary:
- The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH), in partnership with Canadian Blood Services (CBS), will fund applications that are determined to be relevant to the research priority areas described below:
- Blood utilization and conservation.
- Blood products and their derivatives include cellular blood components (red blood cells and platelets), plasma products, therapeutic proteins fractioned from plasma, and replacement products for any of these including both recombinant proteins and synthetic materials. Conservation refers to strategies to reduce the use of donor-derived blood products.
- More information on the research priorities of CIHR-ICRH and CBS can be found on their websites.
Funds Available:
- The term of the grant is up to three years.
- The total number and amount of grants to be funded will be determined by CBS following peer review evaluation.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
- The grant must be held in Canada.
- Funding will be provided directly by the Canadian Blood Services.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
3. Breast Cancer (Updated: 2010-07-15)
Summary:
- The CIHR Institute of Cancer Research (CIHR-ICR), in partnership with Public Health Agency of Canada, will fund applications that are determined to be relevant to the research priority areas described below:
- Mechanisms of breast cancer development
- Molecular detection and prediction of breast cancer
- Personalized medicine and breast cancer
- Breast cancer progression and dissemination
- Psychosocial, survivorship and health services aspect of breast cancer care
- Transferring knowledge into practice.
- More information on the breast cancer research priorities can be found on the web sites of the National Breast Cancer Research Framework.
Funds Available:
- The total amount available for this funding opportunity is $1,435,128. This amount may increase subject to the availability of funds.
- The maximum amount awarded for a single grant will be as recommended by CIHR peer review for a period of two to five years.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
- The grant must be held in Canada.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
4. Ethics (EOG)
Summary:
- The CIHR Ethics Office, in partnership with the Institute of Aboriginal Peoples' Health (CIHR-IAPH) will fund applications that are determined to be relevant to research in ethics related to health, health research and/or health policy:
- A systematic analysis of bioethics or ethics issues associated with health, health care, health research or health policy must be a significant focus of the proposed study. Scientific, social or legal issues, if addressed, should expand the discussion or understanding of bioethical or ethical issues.
- Consideration will also be given to applications concerning ethics in health, health care, health research, or health policy in relation to First Nations, Inuit and/or Métis peoples in Canada.
- More information on the research priorities of CIHR-Ethics Office, and CIHR-IAPH can be found on their websites.
Funds Available:
- The total amount available for this funding opportunity is $600,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $100,000 per annum for up to three years.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
- In order to maximize the number of applications funded through this initiative, the Ethics Office may invite other CIHR branches or Institutes to consider funding relevant applications that receive a score of 3.5 or above. For this purpose, the anonymized application summary will be shared with CIHR branches or CIHR Institutes at the discretion of the CIHR Ethics Branch, according to the Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP).
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
5. Gender, Sex, and Health Research Priorities (OGE)
Summary:
- The CIHR Institute of Gender and Health (CIHR – IGH) will fund applications that are determined to be relevant to the research priority areas described below:
- Self-directed violence, gender, and health
- Interpersonal violence, gender, and health
- Collective, structural or systemic violence, gender, and health
- Knowledge translation and exchange related to violence and health
- Tailoring interventions according to gender or sex
- Improving access to health services by accounting for gender or sex
Funds Available:
- The total amount available for this funding opportunity is $800,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is up to $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
6. Genetics (Ethics, Law and Society) (OGH)
Summary:
- The CIHR Institute of Genetics (CIHR - IG) will fund applications that address ethical, legal and social issues relevant to the design, conduct, and application of research involving genetics and genomics. CIHR - IG is particularly interested in funding projects that will explore new ethical and policy dimensions of genetics research and the application of genetic knowledge.
- A non-exhaustive list of possible research topics that CIHR - IG would welcome include:
- Synthetic Biology
- Integration of information technologies and open source in genetic research
- Pharmacogenetics, genetic biomarker validation, and clinical trials
- Contribution of genetics to global health and neglected disease research
- Rights and responsibilities in relation to genomic biobanks
- Redefinitions of normalcy and disease in the genomics era
- Validity, integrity, and ethical review of genetic research studies
- Biosecurity and biosafety
- Development and application of transgenic animal models
- Public expectations and media coverage of genetics and genomics research
- Regulation and oversight of medical applications incorporating genetic science, such as gene transfer, iPS, and generic bio-pharmaceuticals.
- Genetic knowledge is rapidly transforming many aspects of research, drug development, and clinical practice. Applications of this research will have important implications for Canada's health care system, economy and international commitments. This Priority Announcement is designed to advance research from many disciplines into the ethical, legal and social dimensions of genetic and genomic research. While the IG continues to support quality work in privacy, genetic testing, and biobanking, this announcement also welcomes proposals involving emergent ethical, legal, and social issues in genetic and genomic research.
- This Priority Announcement is designed to solicit small development grant applications for research projects on emergent or unresolved ethical, legal, and social aspects of genetics. Research proposals can include original investigation, analysis, and/or consolidation of previous research. Proposals should meet one or more of the following objectives:
- Systematizing and analyzing current thinking, policies, and practices
- Proposing alterations in policy or practice that would help address emergent or unresolved ethical, legal, and social challenges in genetics
- Identifying further research needs relating to the emergent or unresolved ethical, legal, and social dimensions of genetics.
- More information on the research priorities of the CIHR Institute of Genetics can be found on their website.
Funds Available:
- The total amount available for this initiative is $570,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single systematic review project is $25,000 per annum for up to three years.
- The maximum amount awarded for a single original investigation project (operating grant) is $75,000 per annum for up to three years.
Special Requirements:
- This Priority Announcement will require the completion of an additional Relevance Form.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
7. Health Services and Policy Research (IHS)
Summary:
- The CIHR Institute of Health Services and Policy Research (CIHR-IHSPR) is committed to supporting innovative research, capacity-building and knowledge translation initiatives designed to improve the way health care services are organized, regulated, managed, financed, paid for, used and delivered, in the interest of improving the health and quality of life of all Canadians.
- CIHR-IHSPR will offer one year bridge funding to applications that are determined to be relevant to the research priority areas listed below. These one year operating grants afford principal investigators the opportunity to begin or continue their work without the loss of momentum, staff, or trainees, and to resubmit their research proposal in subsequent competitions.
- Primary and Community-Based Healthcare
- Access to Appropriate Care across the Continuum
- Financing, Sustainability and Governance
- Health Information
- Drug Policy
- Please see CIHR-IHSPR Priority Research Areas for a detailed description of these priority research areas.
Funds Available:
- The total amount available for this funding opportunity is $100,000. This amount may increase.
- The maximum amount awarded for a single grant is $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
8. HIV/AIDS (HOP/HHP)
Summary:
- The CIHR HIV/AIDS Research Initiative will fund applications that have a primary research focus on HIV/AIDS. Applications must also be deemed relevant to one of the following research priority areas of the Initiative:
- Health systems, services and policy;
- Resilience, vulnerability and determinants of health;
- Prevention technologies and interventions;
- Drug development, toxicities and resistance;
- Pathogenesis; and
- Issues of co-infection and co-morbidity.
- For the research priority area of pathogenesis, the CIHR HIV/AIDS Research Initiative encourages, in particular, applications that explore the following research gap: "Immunopathogenesis in Humans", with an emphasis on:
- HIV-induced modulation of host cell gene expression;
- The mechanism(s) by which HIV infection can cause immune hyperactivation; or
- Acquiring a better understanding of the pathogenic mechanisms of B-cell abnormalities in HIV disease.
- Research in any of the six research priority areas described above that also focuses on at risk populations including people living with HIV/AIDS, men who have sex with men, injection drug users, Aboriginal Peoples, prison inmates, youth at risk, women at risk and people from countries where HIV is endemic, is encouraged.
- For more information on the HIV/AIDS research priority areas, visit our web page.
Funds Available:
- The total amount available for this funding opportunity is $1,550,000.
- The maximum amount awarded for a single grant is $150,000 per annum for up to three years.
- Of the total funds available, $1,350,000 will support three-year grants:
- $900,000 is available to fund applications relevant to the Biomedical/Clinical Research funding stream;
- $450,000 is available to fund applications relevant to the Health Services/Population Health Research funding stream.
- In addition, $200,000 is currently available to support bridge grants:
- $100,000 is available to fund applications relevant to the Biomedical/Clinical Research funding stream;
- $100,000 is available to fund applications relevant to the Health Services/Population Health Research funding stream.
- The maximum amount awarded for a single bridge grant is $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
- All applications determined to be relevant to the HIV/AIDS Research Initiative priority areas listed above will be eligible for Bridge Funding.
- Applications to this HIV/AIDS Priority Announcement must select only ONE (i.e., the most relevant) HIV/AIDS priority research area listed above.
- Applications to the CIHR HIV/AIDS Research Initiative are sought in two distinct funding streams: Biomedical/Clinical Research and Health Services/Population Health Research. Although projects which display a multidisciplinary approach are strongly encouraged and accepted, applicants must clearly indicate the most relevant funding stream in the relevance field of their ResearchNet application.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
9. Institute of Nutrition, Metabolism and Diabetes Start up - Assistant Professors, Clinicians, New Investigators (Bridge Funding) (PCN)
Summary:
- This competition provides bridge funding to Assistant Professors, Clinicians and New Investigators working in the broad research areas of the CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR – INMD).
- Competition structure: three funding pools, to support a minimum of one grant per pool:
- Assistant Professors: Assistant Professors as recognized by their host university.
- Clinician Scientists: At the time of application, a candidate must hold a professional degree and have completed at least two years of post graduate clinical training.
- New Investigators: Investigators with less than six years of experience as independent investigators since their first academic appointment.
- More information on the research priorities of CIHR-INMD can be found on their website.
Funds Available:
- The total amount available for this funding opportunity is $300,000. This amount may increase if additional funding partners decide to participate.
- Of this $300,000:
- $100,000 is available to fund applications relevant to the Assistant Professors pool;
- $100,000 is available to fund applications relevant to the Clinician Scientists pool; and
- $100,000 is available to fund applications relevant to the New Investigators pool.
- The maximum amount awarded for a single grant is $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
- Applicants must clearly indicate which of the three funding pools they are targeting. If applicable, applicants can identify up to three pools.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
10. Knowledge Translation (KTE)
Summary:
- The CIHR Knowledge Translation (KT) Branch will fund applications that are determined to be relevant to one or both of the research priority areas described below:
- KT Science (the determinants of knowledge use and effective methods of promoting the uptake of knowledge):
- Increase understanding of the theory and practice of KT
- Develop tools/measures to evaluate the effectiveness/impact of KT practices/interventions
- KT Practice (moving research into action):
- Increase the uptake/application of knowledge to bridge a knowledge to action gap.
- Increase the understanding of knowledge application.
- CIHR's mandate is "to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improve health for Canadian, more effective health services and products and a strengthened Canadian health care system". The purpose of this funding opportunity is to advance KT (synthesis, dissemination, exchange and ethically sound application of knowledge). It is expected that this targeted investment will lead to a better understanding of concepts, theories and practices that underlie effective KT in order to improve the health of Canadian, provide more effective health services and products and strengthen the health care system.
- More information on the research priorities of the KT Branch can be found on their website.
Funds Available:
- The total amount available for this funding opportunity is $200,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
11. Obesity – Interventions to Prevent or Treat (OOP)
Summary:
- The CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD) will fund applications that are determined to be relevant to the research priority areas described below:
- Interventions at the clinical, policy, and population health level focusing on solutions to promote healthy body weight at the population level (e.g., school-based approaches, intervention research).
- Interventions to treat obesity and research to evaluate the outcomes of specialized treatment services
- More information on the research priorities of CIHR-INMD can be found on their website.
Funds Available:
- The total amount available for this funding opportunity is $100,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
- Nominated Principal Investigators are eligible to receive only one grant at a time through INMD's Priority Announcement program. Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator, as of the anticipated start date for funding from INMD's Priority Announcement program, are not eligible for funding from this Priority Announcement
- This Priority Announcement will apply to new grant applications as well as to renewal applications.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
12. Ovarian Cancer (Bridge Funding) (OVA) (Updated: 2010-07-15)
Summary:
- The CIHR Institute of Cancer Research (CIHR-ICR), in partnership with Ovarian Cancer Canada (OCC), will fund applications that are determined to be relevant to the research priority area described below:
- The goal of the priority announcement is to allow Ovarian Cancer Canada (OCC) to support high quality ovarian cancer research. The Program will consider applications to fund projects in any discipline of research that contributes to the acquisition and application of knowledge in the field of ovarian cancer. They can include, but are not limited to:
- Basic research investigating ovarian biology relevant to ovarian cancer.
- Research directed toward an understanding of the causes, development and progression of ovarian cancer.
- Research that aims to identify novel factors (e.g. genetic, lifestyle, environmental) that contribute to the initiation or progression of ovarian cancer.
- Research that addresses the psychological or social needs of women with ovarian cancer.
- Applied research designed specifically to translate promising research advances from basic research into pre-clinical and clinical investigations relevant to the prevention, early detection or treatment of ovarian cancer.
- The Program provides support for research to:
- maintain ovarian cancer research capacity in Canada; and
- allow researchers submitting highly meritorious fundable but not funded ovarian cancer research applications to the CIHR Operating Grants competition, to maintain their research team, and to acquire new research data to strengthen future applications.
- Since applications are adjudicated and administered by CIHR and because these grants are also considered OCC grants, grantees will be required to submit, to ICR and to the OCC office, a summary of the work that has taken place during the tenure of the award that describes how the funding has benefited their research (to the attention of Elisabeth Ross at the OCC address below). Grantees will also be encouraged to present at the biennial Canadian Conference on Ovarian Cancer Research.
- More information on the research priorities of CIHR-ICR and Ovarian Cancer Canada can be found on their web sites.
Funds Available:
- The total amount available for this funding opportunity is $200,000 for one year.
- The maximum amount awarded for a single grant is $100,000 per annum for up to 1 year.
- It is expected that two grants will be funded through this competition
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
- The grant/award must be held in Canada.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
13. Prevention and Treatment of Illicit Drug Use (PTI)
Summary:
- The CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA), will fund applications that are determined to be relevant to the research priority area described below:
- Prevention and Treatment of Illicit Drug Use
- More information on the research priorities of CIHR-INMHA can be found on their website.
Funds Available:
- The total amount available for this funding opportunity is $100,000.
- The maximum amount awarded for a single grant is up to $100,000 per annum for one year.
- CIHR-INMHA anticipates that a minimum of one grant will be funded through this competition.
Specific Requirements:
- This Priority Announcement will not require the completion of a Relevance Form.
- The substances covered by this initiative are illicit drugs such as marijuana, cocaine, heroin, ecstasy and methamphetamine (crystal meth). Other psychoactive substances such as alcohol, psychotropic pharmaceuticals (over-the-counter and prescription), solvents and inhalants can be studied only if they are used in combination with an illicit drug.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
14. Psychosocial Issues Related to Assisted Human Reproduction (PAH)
Summary:
Funds Available:
- The total amount available for this funding opportunity is $500,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is up to $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
15. Regional Partnerships Program:
15a) Regional Partnerships Program - Manitoba (RPA)
Summary:
Funds Available:
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available;
- The maximum amount awarded for a single grant is $100,000 per year for up to two years except where $100,000 is not equivalent to 75% or greater of the approved annual budget of an individual grant, then 75% pro-rated budget amount will apply.
Additional Information:
- For eligibility guidelines, please see the CIHR/Manitoba RPP Program Requirements.
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- The nominated principal applicant must be from an institution in Manitoba;
- Please note researchers must submit their applications at least two weeks prior to the CIHR deadline to have their applications vetted by the internal review procedures at MHRC in order for their grant to be eligible for consideration for RPP funding;
- This Priority Announcement will not require the completion of a Relevance Form;
- When applying through ResearchNet, please ensure to select "RPP-Manitoba" in the drop-down menu of the priority announcement.
Contact Information:
- For questions about the MB Advisory Board RPP review process and criteria, please contact: Shannon Rogalski
Manager, Funding Programs
Manitoba Health Research Council
Phone: 204-783-4249
Email: shannon.rogalski@mhrc.mb.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
15b) Regional Partnerships Program – New Brunswick (RNB)
Summary:
- CIHR, through the Regional Partnerships Program (RPP), in partnership with New Brunswick-RPP is interested in funding applications in all four themes of health research that contribute to the goal of building health research capacity in New Brunswick.
- More information on the research priorities of New Brunswick can be found on their website.
Funds Available:
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available;
- The maximum amount awarded for a single grant is $100,000 per annum for up to five years.
Additional Information:
- For eligibility guidelines, see the New Brunswick and Canadian Institutes of Health Research Regional Partnership Program description;
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- The nominated principal applicant must be from an institution in New Brunswick;
- Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures of the New Brunswick RPP Advisory Board a minimum of two weeks prior to submitting their application to CIHR in order for their grant to be eligible for consideration for RPP funding.
- This Priority Announcement will not require the completion of a Relevance Form;
- When applying through ResearchNet, please ensure to select "RPP-New Brunswick" in the drop-down menu of the priority announcement.
Contact Information:
- For questions about the NB RPP Advisory Board review process and criteria, please contact:
John Boyne
Administrator, Medical Research Fund of New Brunswick
P.O. Box 5100
520 King Street
Fredericton, NB, E3B 5G8
Telephone: 506 444-3222
Fax: 506 453-2958
Email: john.boyne@gnb.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
15c) Regional Partnerships Program – Newfoundland and Labrador (RNL)
Summary:
Funds Available:
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available;
- The maximum amount awarded for a single grant will normally be up to $150,000 per annum for up to three years for new grants, and one year for renewals.
Additional Information:
- For eligibility guidelines, please see the Newfoundland and Labrador RPP program description;
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- The nominated principal applicant must be from an institution in NL;
- Please note researchers must submit their applications at least one month prior to the CIHR application deadline to have their applications vetted by the internal review procedures at RPP-NL in order for their grant to be eligible for consideration for RPP funding. Contact for this process is the Office of Research and Graduate Studies (see contact information below);
- This Priority Announcement will not require the completion of a Relevance Form;
- When applying through ResearchNet, please ensure to select "RPP-Newfoundland and Labrador" in the drop-down menu of the priority announcement.
Contact Information:
- For questions about the RPP-NL internal review process and criteria, please contact:
Office of Research and Graduate Studies
Faculty of Medicine
Memorial University of Newfoundland
Room H-1759, Health Sciences Complex
St. John's, NL, A1B 3V6
Telephone: 709-777-6762
Fax: 709-777-7501
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
15d) Regional Partnerships Program – Nova Scotia (RNS)
Summary:
Funds Available:
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available.
- The maximum amount awarded for a renewal grant is $70,000 per annum for up to 1 year.
- New grants are awarded for up to three years.
Additional Information:
- Please refer to the 2010/11 Nova Scotia - CIHR RPP Requirements document for eligibility criteria, application process and funding details;
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- The nominated principal applicant must be from an institution in Nova Scotia;
- Please note that in order to be considered for RPP funding, researchers must submit their applications electronically to NSHRF within five business days of the CIHR application deadline;
- This Priority Announcement will not require the completion of a Relevance Form;
- When applying through ResearchNet, please ensure to select "RPP-Nova Scotia" in the drop-down menu of the priority announcement;
- As a condition of funding, NSHRF will require that successful applicants provide them with a copy of the CIHR Scientific Officer's Notes.
Contact Information:
- For additional information on NS-RPP eligibility criteria and funding details, please contact:
Jennifer McNutt
Manager, Health Research & Matching Grants Programs
Nova Scotia Health Research Foundation
Telephone: 902-424-3370
Fax: 902-424-7753
E-mail: jennifer.mcnutt@gov.ns.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
15e) Regional Partnerships Program – Prince Edward Island (RPS)
Summary:
- CIHR, through the Regional Partnerships Program (RPP), in partnership with Prince Edward Island-RPP is interested in funding applications that span the four themes of research that contribute to the goal of building health research capacity in PEI. The following areas of research strength at UPEI reflect these four themes:
- Cardiovascular and respiratory health research
- Metabolism, nutrition and diabetes
- Human development and cognition
- Cancer research
- Applied health services and health promotion
- Natural products and human health
- Population health
- More information on the research priorities of Prince Edward Island can be found in the University of Prince Edward Island Strategic Plan and the Province's Island Prosperity Strategy.
Funds Available:
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available;
- The maximum amount awarded for a single grant is $100,000 per annum for up to three years.
Additional Information:
- For eligibility guidelines, see the PEI-CIHR RPP program description.
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- The nominated principal applicant must be from an institution in Prince Edward Island;
- Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures at the Office of Research Development a minimum of two months prior to submitting their application to CIHR in order for their grant to be eligible for consideration for RPP funding;
- This Priority Announcement will not require the completion of a Relevance Form;
- When applying through ResearchNet, please ensure to select "RPP-Prince Edward Island" in the drop-down menu of the priority announcement.
Contact Information:
- For questions about the RPP-PEI internal review process and criteria, please contact:
Research Grants Officer
University of Prince Edward Island
Office of Research & Development
550 University Avenue
Charlottetown, PE, C1A 4P3
Telephone: 902-566-0709
Fax: 902-620-5092
Email: ord@upei.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
15f) Regional Partnerships Program – Saskatchewan (RSN)
Summary:
- CIHR, through the Regional Partnerships Program (RPP), in partnership with Saskatchewan-RPP is interested in funding highly rated applications in Saskatchewan.
- Operating grants from all four themes of research will be supported based upon the rankings that they received. However, half of the available funding will be awarded based upon the following listed research priority areas:
- Health needs of Aboriginal people and seniors;
- Health systems and policy research, with emphasis on: health human resources and workforce planning; quality management and improvement; primary health care; mental health and addictions; innovative delivery models; and rural and remote health services;
- Determinants of health status, including early childhood development and the prevention and underlying causes of chronic and lifestyle-related disease (particularly diabetes, obesity and smoking);
- Public health including infectious diseases and water and food safety;
- Synchrotron-based health research.
- More information on Saskatchewan's research priorities can be found in the Health Research Strategy (Updated: 2010-08-13).
Funds Available:
- The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available;
- The grant amount will be as recommended by CIHR; the duration will be for two years, unless a shorter period is recommended by CIHR.
Additional Information:
- For eligibility criteria and funding details, please see the Saskatchewan - CIHR RPP Policies (Updated: 2010-08-13);
- Recipient(s) will be the top ranked researcher(s) that meet(s) RPP eligibility requirements;
- The nominated principal applicant must be from an institution in Saskatchewan;
- The grant is non-renewable for the first re-application following RPP funding;
- Funding is conditional upon the availability of funds;
- Please note that researchers must have their CIHR applications vetted by the internal review procedures at their University or institution prior to submitting to CIHR in order for their grant to be eligible for consideration for RPP funding:
- University of Saskatchewan - four weeks prior to CIHR application deadline.
- University of Regina - four weeks prior to CIHR application deadline.
- This Priority Announcement will require the completion of a Relevance Form;
- When applying through ResearchNet, please ensure to select "RPP-Saskatchewan" in the drop-down menu of the priority announcement.
Contact Information:
- For questions about the RPP-SK internal review process and criteria, please contact:
Research Services
University of Saskatchewan
Box 5000 RPO University
Saskatoon, SK, S7N 4J8
Telephone: 306-966-8576
Fax: 306-966-8597
E-mail: research.services@usask.ca
Or
Office of Research Services
University of Regina
3737 Wascana Parkway
Regina, SK, S4S 0A2
Telephone: 306-585-4775
Fax: 306-585-4893
E-mail: research.services@uregina.ca
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
16. Reproductive and Child Heath (Start-up Grants) (IHD)
Summary:
- The CIHR Institute of Human Development, Child and Youth Health (CIHR-IHDCYH), will fund applications that are determined to be relevant to the research priority areas described below:
- Research priority areas of CIHR-IHDCYH.
- The objective of this priority announcement is to further strengthen research that relates to the research priorities areas of the CIHR-IHDCYH by increasing research capacity. It is expected that this targeted investment will lead to increased success rates for new Principal Investigators in future CIHR regular open competitions.
Funds Available:
- The total amount available for this funding opportunity is $100,000.
- The maximum amount awarded for a single grant is $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
- Grants are offered only to investigators with less than six years of experience as independent investigators since their first academic appointment (i.e., after September 2004, including experience outside Canada) and who have never held a CIHR grant as a Principal Investigator (including the Sick Kids Foundation (SKF)/IHDCYH New Investigators Grants Program).
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
17. Sodium and Health (OSO)
Summary:
- The CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD), in partnership with the CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH) and the CIHR Institute of Human Development, Child and Youth Health (CIHR-IHDCYH) will fund applications that are determined to be relevant to the research priority areas described below:
- mechanisms underlying salt induced health risk;
- biomarkers for salt and links to health outcomes;
- physiologic, immune, neurological, and renal mechanisms controlling salt intake, salt distribution, and salt excretion;
- optimal sodium intakes in pregnancy and childhood, with long-term impact on blood pressure and cardiovascular disease and non-CVD (including bone health and cancers); and
- impact and risks of a low sodium diet, low serum sodium, and lowered blood pressure.
- More information on the research priorities of CIHR-INMD, CIHR-ICRH and CIHR-IHDCYH can be found on their websites.
Funds Available:
- The total amount available for this funding opportunity is $900,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $150,000 per annum for up to three years.
- Equipment may be included in the first year.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
- The grant must be held in Canada.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
18. Transfusion Related Acute Lung Injury (TRALI) (TRA)
Summary:
- The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH), in partnership with Canadian Blood Services (CBS), will fund applications that are determined to be relevant to the research priority areas described below:
- Transfusion related acute lung injury (TRALI).
- Research projects may focus on any relevant research question within biomedical, clinical, or health policy research. Examples of relevant questions include defining the scope of TRALI, mechanisms of induction of TRALI in both animal models and patient populations, identification of pathogenic antibodies, identification of best testing methods, studies to inform donor deferral policy making, identification of factors (including genetic factors) that increase a recipient's susceptibility to TRALI, and epidemiology studies to establish the incidence of TRALI.
- More information on the research priorities of CIHR-ICRH and CBS can be found on their websites.
Funds Available:
- The term of the grant is up to three years.
- The total number and amount of grants to be funded will be determined by CBS following peer review evaluation.
Specific Requirements:
- This Priority Announcement will require the completion of a Relevance Form.
- The grant must be held in Canada.
- Funding will be provided directly by the Canadian Blood Services.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
B. Research Related to CIHR Institute Mandates:
19. Cancer Research (Bridge Funding) (IC1)
Summary:
- The CIHR Institute of Cancer Research (CIHR-ICR), will fund applications that are determined to be relevant to the research priority areas described below:
- The objective of the CIHR - ICR Bridge Funding Operating Grants is to ensure the establishment or the maintenance of excellent research programs. These one-year operating grants give new principal investigators the possibility to strengthen their proposals before resubmitting them, and they afford established principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees.
- More information on the research priorities of CIHR-ICR can be found on its websites.
Funds Available:
- The total amount available for this funding opportunity is $300,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will not require the completion of a Relevance Form.
- CIHR - ICR must be identified as the primary Institute affiliation in the "Suggested CIHR Institute" section of the operating grant application.
- Research proposals must fall within CIHR - ICR's mandate.
- Provided eligible candidates remain for consideration, at least two of the grants will be allocated to new investigators, who are researchers with less than four years of experience as independent investigators since their first academic appointment, and who have never held a CIHR grant as principal investigator. Any additional funding will be allocated to the next ranked new investigator first, then the next ranked established investigator.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
20. Circulatory and Respiratory Health (Bridge Funding) (CRH)
Summary:
- The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH) Bridging Operating Grant Program (One-Year) is designed to fund highly ranked operating grant applications relevant to CIHR-ICRH's mandate that have just missed the CIHR Operating Grants competition funding cut-off. These one-year operating grants afford Principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.
Funds Available:
- The total amount available for this funding opportunity is $100,000. This amount may increase should additional funds become available during the competition.
- The maximum amount awarded for a single grant is $100,000 per annum for up to one year.
- Subject to the availability of funds, a minimum of one grant will be awarded in the area of cardiovascular research and a minimum of one grant will be awarded in the area of respiratory research. If only one grant can be supported through this competition, the top ranked application will be funded.
Specific Requirements:
- This Priority Announcement will not require the completion of a Relevance Form.
- The grant must be held in Canada.
- CIHR - ICRH must be identified as the primary Institute affiliation in the "Suggested CIHR Institute" section of the operating grant application.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
21. Genetics: Bridge Funding (IG1)
Summary:
- The CIHR Institute of Genetics (CIHR - IG) Bridging Operating Grant (One-Year) Program is designed to fund highly ranked operating grant applications relevant to CIHR - IG's mandate that have just missed the CIHR Operating Grants competition funding cut-off. These one-year operating grants afford Principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees.
- CIHR - IG will fund applications that are determined to be relevant to its mandate:
- To support research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries.
- More information on the research priorities of CIHR - IG can be found on its website.
Funds Available:
- The total amount available for this funding opportunity is $300,000.
- The maximum amount awarded for a single grant is $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will not require the completion of a Relevance Form.
- All CIHR operating grant applications that meet the following criteria will be considered for CIHR - IG Bridge Funding:
- CIHR - IG has been identified as the primary or secondary Institute affiliation in the "Suggested CIHR Institute"; and
- the research proposal falls within CIHR - IG's mandate.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
22. Genetics: Maud Menten New Principal Investigator Prizes (MMB / MMC/ MMH)
Summary:
- This program is designed to recognize and support the research excellence of Canadian New Investigators working within the CIHR – Institute of Genetics' (CIHR – IG) mandate. The research grant is intended to offset the direct costs of the recipient's research program.
- CIHR - IG established the Maud Menten New Principal Investigator Prize. Dr. Menten's outstanding career as a biomedical scientist led to many achievements including important co-discoveries relating to blood sugar, haemoglobin and kidney functions. In 1913, a collaboration with Leonor Michaelis on the behaviour of enzymes resulted in the Michaelis-Menten equation, a biochemical concept so fundamental that it is familiar to first-year science students.
- More information on the research priorities of CIHR-IG can be found on its website.
Funds Available:
- The CIHR - IG Maud Menten New Investigator Prizes consist of a one-year, non-renewable $30,000 research grant.
- One prize in each of the following research areas is available: i) biomedical; ii) clinical; and iii) health services/population health, including genetic ethical, legal and social issues.
- For each research area CIHR-IG also makes available two finalist prizes. Finalist prizes consist of a one-year, non-renewable $1,000 research grant.
- The total amount available for this funding opportunity is $96,000. Of this total amount:
- $32,000 is available to fund applications in the area of biomedical research
- $32,000 is available to fund applications in the area of clinical research
- $32,000 is available to fund applications in the area of health services/population health, including genetic ethical, legal and social issues research
Specific Requirements:
- This Priority Announcement will not require the completion of a Relevance Form.
- All Nominated Principal Investigators who meet the following criteria will be considered for the CIHR-IG Maud Menten New Principal Investigator Prize (2010):
- successful in either the September 2010 or March 2011 CIHR Operating Grants competition with a rating of 4.0 or greater;
- identified CIHR-IG as their primary or secondary Institute affiliation in the "Suggested CIHR Institute" section of their operating grant application; and
- held a full-time appointment as an independent investigator, while actively engaged in CIHR research, including research performed in non-academic setting (e.g., industry, government) for a period of less than 60 months before the competition deadline associated with their successful operating grant application (i.e., September 15 for the 2010 competition and March 1 for the 2011 competition).
- The New Principal Investigator with the highest ranked CIHR Operating Grant application - from the combined results of the September 2010 and March 2011 CIHR Operating Grant competitions - in each research area will be the recipient of one of the three prizes. For each research area, two finalist prizes are also available and will be selected in rank order.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
23. Institute of Infection and Immunity (Bridge Funding) (III)
Summary:
- The CIHR Institute of Infection and Immunity (CIHR-III) will offer one year bridge funding for applications that are determined to be relevant to the Institute's mandate.
Funds Available:
- The total amount available for this initiative is $400,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will not require the completion of a Relevance Form.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
24. Institute of Neurosciences, Mental Health and Addiction (Bridge Funding) (INO)
Summary:
- The objective of the CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR - INMHA) Bridge Funding Operating Grant is to ensure the establishment of excellent research programs related to CIHR - INMHA's mandate area.
- These operating grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.
Funds Available: (Updated: 2010-08-20)
- The total amount available for this initiative is $200,000. This amount may increase should additional funds become available during the competition.
- The maximum amount awarded for a single grant is up to $100,000 per annum for up to one year.
- $100,000 will be provided to applications that include an epigenetics component.
Specific Requirements:
- CIHR - INMHA must be identified as the primary Institute affiliation in the "Suggested CIHR Institute" section of the operating grant application.
- Research proposals must fall within CIHR - INMHA's mandate.
- The grant must be held in Canada.
- Nominated Principal Investigators are eligible to receive only one grant at a time through CIHR - INMHA's Priority Announcement program. Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator, as of the anticipated start date for funding from CIHR - INMHA's Priority Announcement program, are not eligible for funding from this Priority Announcement
- This Priority Announcement will apply only to new grant applications and not to renewal applications.
- This Priority Announcement will not require the completion of a Relevance Form.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
25. Musculoskeletal Health, Arthritis, Skin and Oral Health (IMH)
Summary:
- The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA), will fund applications that are determined to be relevant to the research priority areas described below:
- Research priorities of CIHR-IMHA
- More information on the research priorities of CIHR-IMHA can be found on their website.
Funds Available:
- The total amount available for this initiative is $400,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is $100,000 per annum for one year.
Specific Requriements:
- At least half of the grants will be allocated to new investigators (A new investigator is defined as a researcher who has completed all formal training, but with five years or less experience as an independent investigator. One does NOT need a new investigator salary award to be classified as a new investigator.). Any additional funding will be allocated to the next top ranked new investigator first, then the next top ranked established investigator.
- Nominated Principal Investigators are eligible to receive only one grant at a time through CIHR - IMHA's priority announcement program. Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator, as of the anticipated start date for funding from CIHR - IMHA's priority announcement program, are not eligible for funding from this priority announcement.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
26. Institute of Nutrition, Metabolism and Diabetes (Bridge Funding) (NMD)
Summary:
- The CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD), will fund applications that are determined to be relevant to the mandate of CIHR - INMD.
- More information on the mandate of CIHR-INMD can be found on their website.
- These operating grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.
Funds Available:
- The total amount available for this funding opportunity is $100,000. This amount may increase if additional funding becomes available.
- The maximum amount awarded for a single grant is $100,000 per annum for up to one year.
Specific Requirements:
- This Priority Announcement will not require the completion of a Relevance Form.
- CIHR - INMD must be identified as the primary or secondary Institute affiliation in the "Suggested CIHR Institute" section of the operating grant application.
- Nominated Principal Investigators are eligible to receive only one grant at a time through CIHR - INMD's Priority Announcement program. Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator, as of the anticipated start date for funding from CIHR - INMD's Priority Announcement program, are not eligible for funding from this Priority Announcement.
- This Priority Announcement will apply to new grant applications as well as to renewal applications.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
27. Spinal Cord Research (Prize) (SCR)
Summary:
- The CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA), in partnership with Barbara Turnbull Foundation for Spinal Cord Research (BTF) and NeuroScience Canada (NSC), will fund applications that are determined to be relevant to the research priority areas described below.
- Spinal cord injury protection, repair and functional recovery.
- More information on the research priorities of CIHR-INMHA, the Barbara Turnbull Foundation for Spinal Cord Research (BTF) and NeuroScience Canada (NSC) can be found on their websites.
- The award will be in the form of a top up to an operating grant and will be known as the Barbara Turnbull Award for Spinal Cord Research. The recipient of the award will be selected as the top ranked spinal cord researcher as identified through a keyword search of the combined results of CIHR's September 2010 and March 2011 investigator-initiated open operating grant competitions.
Funds Available:
- The total amount available for this funding opportunity is $50,000. This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single grant is up to $50,000 per annum for one year.
Specific Requirements:
- This Priority Announcement will not require the completion of a Relevance Form.
- The award is non-renewable.
- The grant must be held in Canada.
- Recipient will be the top ranked researcher in spinal cord research.
Contact Information:
- For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
- For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information".
Top
Eligibility
For Eligibility, Guidelines and Performance Measurement please refer to the Operating Grant: 2010-2011 funding opportunity.
Top
Guidelines
For Eligibility, Guidelines and Performance Measurement please refer to the Operating Grant: 2010-2011 funding opportunity.
Top
Performance Measurement
For Eligibility, Guidelines and Performance Measurement please refer to the Operating Grant: 2010-2011 funding opportunity.
Top
Review Process and Evaluation
A. CIHR Research Priority Areas
Relevance Review:
CIHR and partner organizations will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described under "CIHR Research Priority Areas" within the Objectives section.
Prior to peer review, CIHR and the partner organizations will have access to a completed relevance form in addition to anonymized project titles and summaries, provided that applicants have consented to the sharing of information in consideration for other funding opportunities as well as to the sharing of information to observers in completing their ResearchNet application. This information will be used to review applications to determine the relevance, or alignment, of the research proposed to the research priority area(s) described above.
Funding Decision:
Upon completion of peer review, the CIHR and the partner organizations will receive the ranking list, ratings, recommendations on funding level and grant or award term for those applications that 1) are found to be relevant to the research priority areas described under "CIHR Research Priority Areas"; and 2) (unless otherwise specified) are rated within the CIHR fundable range but are not funded through the regular CIHR competition to which they were submitted.
These applications will be funded from the top down in order of ranking as far as budgets will allow.
Applications that receive a ranking below 3.5 will not be funded.
Peer review committees will not be informed of applications submitted for funding through this announcement.
B. Research Related to CIHR Institute Mandates
Funding Decision:
Upon completion of peer review, representatives of each CIHR Institute will receive a randomized list of applications for which the Institute was selected as primary (and where indicated, secondary) Institute under "Suggested Institutes" on the "Project Descriptors" page of the ResearchNet application. The randomized list will include titles, project summaries and peer review committee recommendations on funding levels. The summaries will be used to determine the relevancy of the research to the mandate of the Institute.
Eligible applications will be funded from the top down in order of ranking as far as budgets will allow.
Applications that receive a rating below 3.5 will not be funded.
Peer review committees will not be informed of applications submitted for funding through this announcement.
For Peer Review and Evlauation Criteria please refer to the Operating Grant: 2010-2011 funding opportunity.
Top
How to Apply
Note: This funding opportunity requires the use of ResearchNet to apply for funding.
- The application process for this funding opportunity is comprised of two steps: Registration and Application.
- Both Registration and Application are submitted through the "201009MOP" competition of the Operating Grant: 2010-2011 funding opportunity.
- To complete your Registration and Application, review the Operating Grant: 2010-2011 funding opportunity and then follow the specific application guidelines and instructions which are fully described in its "How to Apply" section.
- An overview of CIHR's application processes can be found under Apply for Funding.
- Reminder to applicants: Please ensure that your application is complete (including all required signatures) and submitted on time to CIHR. Effective September 1, 2008, CIHR will assume no responsibility in following-up with applicants who submit an incomplete application. Incomplete or late applications will not be accepted into the competition.
Submission Requirements:
A. CIHR Research Priority Areas:
- Priority announcements for research in specific CIHR priority areas are listed in the "Objectives" section of this funding opportunity, under "CIHR Research Priority Areas."
- To apply for funding through these priority announcements, select the priority announcement title and relevant research area(s) addressed by your research proposal in the "Identify Priority Announcements and Relevant Research Area" section of your ResearchNet application.
- Applicants may request that their application be considered for up to three priority announcement research areas per application, in each Operating Grant competition.
B. Research Related to CIHR Institute Mandates:
- Priority announcements for research related to CIHR Institute mandates (including bridge funding priority announcements) are listed in the "Objectives" section of this funding opportunity, under "Research Related to CIHR Institute Mandates."
- When you select a CIHR Institute as a primary (and where indicated, secondary) Institute under "Suggested Institutes" on the "Project Descriptors" page of your ResearchNet application, the Institute will automatically consider your application for funding through the priority announcement process whenever it offers a priority announcement for research related to its mandate. Consideration for funding through CIHR Institute mandate priority announcements is in addition to consideration for priority announcement funding in specific research priority areas.
- Applicants to the Operating Grant Program may request that their application be considered for any number of additional Priority Announcements for research related to a CIHR Institute's mandate, Linked Programs, for example, the Regional Partnerships Program, the Neuromuscular Research Program (Spring competitions only), and the CIHR-Arthritis Society Partnership Program.
Top
Contact Information
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
CIHR Info Desk Service
Canadian Institutes of Health Research
Telephone: 613-954-1968
Toll-free: 1-888-603-4178
Email: info@cihr-irsc.gc.ca
Specific information about the Operating Grant Program peer review committees can also be obtained by contacting the individuals listed on the CIHR Committees and Programs Contacts page of the CIHR website.
If you are experiencing technical difficulties with your ResearchNet account or the e-Submission process contact:
CIHR ResearchNet Support
Canadian Institutes of Health Research
Telephone: 613-941-9080
Email: support@researchnet-recherchenet.ca
Top
Additional Information
A. CIHR Research Priority Areas:
1. Blood Supply Risk
- For questions about this initiative and research objectives contact:
Jennifer Ralph
Project Manager, Strategic Initiatives and Evaluation
CIHR Institute of Circulatory and Respiratory Health (CIHR – ICRH)
Telephone: 613-941-0086
Fax: 613-954-1800
Email: jennifer.ralph@cihr-irsc.gc.ca
2. Blood Utilization and Conservation
- For questions about this initiative and research objectives contact:
Jennifer Ralph
Project Manager, Strategic Initiatives and Evaluation
CIHR Institute of Circulatory and Respiratory Health (CIHR – ICRH)
Telephone: 613-941-0086
Fax: 613-954-1800
Email: jennifer.ralph@cihr-irsc.gc.ca
3. Breast Cancer (Updated: 2010-07-15)
- For questions about this initiative and research objectives contact:
Benoît Lussier
Assistant Director
CIHR – ICR
Telephone: 514-398-4964
Fax: 514-398-8845
Email: benoit.lussier@mcgill.ca
4. Ethics
- For questions about this initiative and research objectives contact:
Lynne Cayer
Ethics Policy Advisor
CIHR Ethics Office
Telephone: 613-952-4264
Fax: 613-954-1800
Email: lynne.cayer@cihr-irsc.gc.ca
5. Gender, Sex, and Health Research Priorities
- For questions about this initiative and research objectives contact:
Abigail Forson
Assistant Director
CIHR Institute of Gender and Health (CIHR – IGH)
Tel: 613-954-0616
Fax: 613-954-1800
Email: abigail.forson@cihr-irsc.gc.ca
6. Genetics (Ethics, Law and Society)
- For questions about this initiative and research objectives contact:
Ursula Danilczyk, PhD
Assistant Director
CIHR Institute of Genetics (CIHR – IG)
Telephone: 416-813-7670
Fax: 416-813-7673
Email: ursulaig@sickkids.ca
7. Health Services and Policy Research
- For questions about this initiative and research objectives contact:
Michèle O'Rourke
Associate, Strategic Initiatives
CIHR Institute of Health Services and Policy Research (CIHR – IHSPR)
Telephone: 613-952-4539
Fax: 613-954-1800
Email: michele.orourke@cihr-irsc.gc.ca
8. HIV/AIDS
- For questions about this initiative and research objectives contact:
Jane Hutchison
Associate
CIHR HIV/AIDS Research Initiative
Telephone: 613-948-9396
Fax: 613-954-1800
Email: jane.hutchison@cihr-irsc.gc.ca
9. INMD - Start up - Assistant Professors, Clinicians, New Investigators (Bridge Funding)
- For questions about this initiative and research objectives contact:
Paul Bélanger
Assistant Director - Ottawa
CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR – INMD)
Telephone: 613-941-6465
Fax: 613-954-1800
Email: paul.belanger@cihr-irsc.gc.ca
10. Knowledge Translation
- For questions about this initiative and research objectives contact:
Alison Lott
Senior Knowledge Translation Specialist
CIHR – Knowledge Translation Branch
Telephone: 613-948-2682
Fax: 613-954-1800
Email: alison.lott@cihr-irsc.gc.ca
11. Obesity – Interventions to Prevent or Treat
- For questions about this initiative and research objectives contact:
Paul Bélanger
Assistant Director - Ottawa
CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR – INMD)
Telephone: 613-941-6465
Fax: 613-954-1800
Email: paul.belanger@cihr-irsc.gc.ca
12. Ovarian Cancer (Bridge Funding) (Updated: 2010-07-15)
- For questions about this initiative and research objectives contact:
David Hartell
Associate, Institute Strategic Initiatives
CIHR – ICR and III
Telephone: 613-941-4329
Fax: 613-954-1800
E-mail: david.hartell@cihr-irsc.gc.ca
Elisabeth Ross
Chief Executive Officer, Ovarian Cancer Canada
Telephone: 416-962-2700
Fax: 416-962-2701
E-mail: eross@ovariancanada.org
13. Prevention and Treatment of Illicit Drug Use
- For questions about this initiative and research objectives contact:
Nathalie Gendron
Assistant Director
CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA)
Telephone: 613-948-4877
Fax: 613-954-1800
Email: nathalie.gendron@cihr-irsc.gc.ca
14. Psychosocial Issues Related to Assisted Human Reproduction
- For questions about this initiative and research objectives contact:
Abigail Forson
Assistant Director
CIHR Institute of Gender and Health (CIHR-IGH)
Telephone: 613-954-0616
Fax: 613-954-1800
Email: abigail.forson@cihr-irsc.gc.ca
15. Regional Partnerships Program
- For questions on CIHR funding guidelines, how to apply, the peer review process and the RPP policies contact:
Regional Partnerships Program Coordinator
Targeted Initiatives Branch
Canadian Institutes of Health Research
Telephone: 613-952-5728
Fax: 613-954-1800
Email: RPP-PPR@cihr-irsc.gc.ca
- For questions about this initiative and research objectives contact:
Erik Blache
Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: erik.blache@cihr-irsc.gc.ca
16. Reproductive and Child Heath (Start-up Grants)
- For questions about this initiative and research objectives contact:
Anne-Cécile Desfaits, PhD
Assistant Director
CIHR Institute of Human Development, Child and Youth Health (CIHR – IHDCYH)
Telephone: 514-412-4414
Fax: 514-412-4253
Email: anne-cecile.desfaits@cihr-irsc.gc.ca
17 Sodium and Health
- For questions about this initiative and research objectives contact:
Paul Bélanger
Assistant Director - Ottawa
CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR – INMD)
Telephone: 613-941-6465
Fax: 613-954-1800
Email: paul.belanger@cihr-irsc.gc.ca
18. Transfusion Related Acute Lung Injury (TRALI)
- For questions about this initiative and research objectives contact:
Jennifer Ralph
Project Manager, Strategic Initiatives and Evaluation
CIHR Institute of Circulatory and Respiratory Health (CIHR – ICRH)
Telephone: 613-941-0086
Fax: 613-954-1800
Email: jennifer.ralph@cihr-irsc.gc.ca
B. Research Related to CIHR Institute Mandates:
19. Cancer Research (Bridge Funding)
- For questions about this initiative and research objectives contact:
Benoît Lussier, Ph.D.
Assistant Director
CIHR Institute of Cancer Research (CIHR - ICR)
Telephone: 514-398-4964
Fax: 514-398-8845
Email: benoit.lussier@mcgill.ca
20. Circulatory and Respiratory Health (Bridge Funding)
- For questions about this initiative and research objectives contact:
Jennifer Ralph
Project Manager, Strategic Initiatives and Evaluation
CIHR Institute of Circulatory and Respiratory Health (CIHR – ICRH)
Telephone: 613-941-0086
Fax: 613-954-1800
Email: jennifer.ralph@cihr-irsc.gc.ca
21. Genetics: Bridge Funding
- For questions about this initiative and research objectives contact:
Jennifer Ahlgren
Institute Project Officer
CIHR Institute of Genetics (CIHR – IG)
Telephone: 613-957-6126
Fax: 613-954-1800
Email: jennifer.ahlgren@cihr-irsc.gc.ca
22. Genetics: Maud Menten New Principal Investigator Prizes
- For questions about this initiative and research objectives contact:
Jennifer Ahlgren
Institute Project Officer
CIHR - Institute of Genetics (CIHR-IG)
Telephone: 613-957-6126
Fax: 613-954-1800
Email: jennifer.ahlgren@cihr-irsc.gc.ca
23. Institute of Infection and Immunity (Bridge Funding)
- For questions about this initiative and research objectives contact:
Serge Desnoyers
Assistant Director
CIHR Institute of Infection and Immunity (CIHR – III)
Telephone: 418-656-4141 ext. 46251
Fax: 418-577-4698
Email: Serge.Desnoyers@crchul.ulaval.ca
24. Institute of Neurosciences, Mental Health and Addiction (INMHA) Bridge Funding Operating Grant
- For questions about this initiative and research objectives contact:
Nathalie Gendron
Assistant Director
CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA)
Telephone: 613-948-4877
Fax: 613-954-1800
Email: nathalie.gendron@cihr-irsc.gc.ca
25. Musculoskeletal Health, Arthritis, Skin and Oral Health
- For questions about this initiative and research objectives contact:
Tanya Gallant
Program Manager/Analyst
CIHR Institute of Musculoskeletal Health and Arthritis (CIHR – IMHA)
Telephone: 613-954-3469
Fax: 613-954-1800
Email: tanya.gallant@cihr-irsc.gc.ca
26. Institute of Nutrition, Metabolism and Diabetes (Bridge Funding)
- For questions about this initiative and research objectives contact:
Paul Bélanger
Assistant Director - Ottawa
CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR – INMD)
Telephone: 613-941-6465
Fax: 613-954-1800
Email: paul.belanger@cihr-irsc.gc.ca
27. Spinal Cord Research (Prize)
- For questions about this initiative and research objectives contact:
Nathalie Gendron
Assistant Director
CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA)
Telephone: 613-948-4877
Fax: 613-954-1800
Email: nathalie.gendron@cihr-irsc.gc.ca
Top
|
